Drnovšek J, Homan M, Zidar N, Šmid LM.

. Pathogenesis and potential reversibility of intestinal metaplasia – a milestone in gastric carcinogenesis.

Radiol Oncol 2024; 21;58(2):186-195.

Feakins R, Borralho Nunes P, Driessen A, Gordon IO, Zidar N, Baldin P, Christensen B, Danese S, Herlihy N, Iacucci M, Loughrey MB, Magro F, Mookhoek A, Svrcek M, Rosini F.

Definitions of histological abnormalities in inflammatory bowel disease: an ECCO position paper.

J Crohns Colitis 2024; 18(2):175-191.

Jerala M, Remic T, Hauptman N, Zidar N.

Fibrosis-Related microRNAs in Crohn’s Disease with Fibrostenosis and Inflammatory Stenosis.

Int J Mol Sci. 2024 Aug 13;25(16):8826.

Jerala M, Remic T, Hauptman N, Homan P, Zajšek N,Petitjean M, Chen L, Zidar N.

Thrombospondin 2, matrix Gla protein and digital analysis identified distinct fibroblast populations in fibrostenosing Crohn’s disease.

Sci Rep. 2024 Jun 14;14(1):13810.

Pintar T, Tavčar M, Šušteršič A, Volavšek M.

Primary sclerosing encapsulating peritonitis: a case report.

Journal of Medical Case Reports (2023) 17:318.

Novak G, Sever N, Hanžel J, Koželj M, Kurent T, Smrekar N, Drobne D, Zidar N.

Biopsies from ulcer edge yield higher histological activity scores than biopsies from non-ulcerated mucosa in active ulcerative colitis.

Eur J Gastroenterol Hepatol 2023 May 1; 35(5):553-558.